World's Best Scientists 2026 revealed!
Volkmar Müller

Volkmar Müller

D-Index & Metrics

Medicine

D-Index
83
Citations
26425
World Ranking
15566
National Ranking
821

Overview

Volkmar Müller is affiliated with Universität Hamburg in Germany, focusing extensively on medical research, particularly within oncology and related biomedical sciences. Their scholarly output includes publications spanning the fields of Medicine and Biochemistry, Genetics and Molecular Biology.

The scientist's work concentrates mainly on the subfields of Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology, and Genetics. Their research topics primarily involve Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies, HER2/EGFR in Cancer Research, Cancer Genomics and Diagnostics, Cancer Treatment and Pharmacology, Brain Metastases and Treatment, and Cancer Cells and Metastasis.

Among their recent publications are:

  • "Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo," 2020, Annals of Oncology
  • "Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial," 2024, Nature Medicine
  • "Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity," 2020, EMBO Molecular Medicine
  • "AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021," 2021, Breast Care
  • "Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status," 2021, European Journal of Cancer

Frequent co-authors collaborating with Müller include:

  • Peter A. Fasching
  • Tanja Fehm
  • Andreas Schneeweiß
  • Wolfgang Janni
  • Diana Lüftner

Publication venues where Müller has repeatedly contributed include:

  • Geburtshilfe und Frauenheilkunde
  • Senologie - Zeitschrift für Mammadiagnostik und -therapie
  • Cancer Research
  • Breast Care
  • Cancers

The volume of publications highlights a strong emphasis on oncology-related studies, particularly targeting breast cancer therapies and diagnostics. Müller's involvement covers both fundamental cancer biology and clinical treatment research, addressing aspects like immune response predictors, tumor markers, and therapeutic approaches.

Best Publications

  • Tumour exosome integrins determine organotropic metastasis

    Ayuko Hoshino;Bruno Costa-Silva;Tang-Long Shen;Goncalo Rodrigues

  • Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

    Sabine Riethdorf;Herbert Fritsche;Volkmar Müller;Thomas Rau

  • Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer.

    Rashmi K Murthy;Sherene Loi;Alicia Okines;Elisavet Paplomata

  • A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors

    Martin Filipits;Margaretha Rudas;Raimund Jakesz;Peter Dubsky

  • Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups

    Michael Untch;Peter A. Fasching;Gottfried E. Konecny;Stephan Hasmüller

  • Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial

    Sabine Riethdorf;Volkmar Müller;Liling Zhang;Thomas Rau

  • Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer

    Carina Roth;Brigitte Rack;Volkmar Müller;Wolfgang Janni

  • Circulating Tumor Cells in Breast Cancer: Correlation to Bone Marrow Micrometastases, Heterogeneous Response to Systemic Therapy and Low Proliferative Activity

    Volkmar Müller;Nicole Stahmann;Sabine Riethdorf;Thomas Rau

  • Intracranial efficacy and survival with tucatinib plus trastuzumab and capecitabine for previously treated HER2-positive breast cancer with brain metastases in the HER2CLIMB trial

    Nancy U. Lin;Virginia Borges;Carey Anders;Rashmi K. Murthy

  • HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

    Tanja Fehm;Volkmar Müller;Bahriye Aktas;Wolfgang Janni

  • The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.

    Monica M. Montano;Volkmar Müller;Angela Trobaugh;Benita S Katzenellenbogen

  • A clinically relevant gene signature in triple negative and basal-like breast cancer

    Achim Rody;Thomas Karn;Cornelia Liedtke;Lajos Pusztai

  • Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients.

    Corinna Eichelser;Isabel Stückrath;Volkmar Müller;Karin Milde-Langosch

  • Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial.

    Eric Hahnen;Bianca Lederer;Jan Hauke;Sibylle Loibl

  • Prognosis of Women With Primary Breast Cancer Diagnosed During Pregnancy: Results From an International Collaborative Study

    Frédéric Amant;Gunter von Minckwitz;Sileny N. Han;Marijke Bontenbal

  • Treatment of breast cancer during pregnancy: an observational study

    Sibylle Loibl;Sileny N Han;Gunter von Minckwitz;Marijke Bontenbal

  • Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials

    Gunter von Minckwitz;Michael Untch;Eveline Nüesch;Sibylle Loibl

  • Breast cancer brain metastases: biology and new clinical perspectives.

    Isabell Witzel;Leticia Oliveira-Ferrer;Klaus Pantel;Volkmar Müller

  • Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer

    Xiaodan Meng;Volkmar Müller;Karin Milde-Langosch;Fabian Trillsch

  • Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials

    François Clément Bidard;François Clément Bidard;Tanja Fehm;Michail Ignatiadis;Jeffrey B. Smerage

Frequent Co-Authors

Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Tanja Fehm
Tanja Fehm Heinrich Heine University Düsseldorf
Andreas Schneeweiss
Andreas Schneeweiss German Cancer Research Center
Klaus Pantel
Klaus Pantel Universität Hamburg
Michael Untch
Michael Untch Helios Klinikum Berlin-Buch
Jens Huober
Jens Huober Kantonsspital St. Gallen
Sibylle Loibl
Sibylle Loibl Goethe University Frankfurt
Carsten Denkert
Carsten Denkert Philipp University of Marburg
Christoph Thomssen
Christoph Thomssen University of Göttingen
Christian Jackisch
Christian Jackisch Breast Cancer Research Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring career opportunities in medicine doesn’t always mean starting with a traditional MD program. For those looking for flexibility, there are several online degrees and alternative career pathways in the nursing field that can be pursued entirely online or with minimal in-person requirements.

If you’re currently a registered nurse, you might consider advancing your education with an online rn to bsn no clinicals program. These programs are designed for working professionals, letting you complete your degree without committing to additional clinical hours.

Looking to specialize or move into leadership roles? Consider the shortest online dnp program, which allows nurses to earn a Doctor of Nursing Practice degree in less time than traditional, in-person options. Budget-conscious students can also explore the cheapest dnp program to take advantage of cost savings without sacrificing quality.

For those just starting out in healthcare, lpn programs offer a fast-track route into nursing. These programs provide the foundational knowledge needed to begin a rewarding healthcare career and can often be completed rapidly online.

Best Scientists Citing Volkmar Müller

Trending Scientists

Recently Published Articles